StockTipsArenaBeta

BUY Gland Pharma Limited — Chandan Taparia, Motilal Oswal

BUYGland Pharma Limited

byChandan Taparia, Motilal OswalHorizon: BTST26 Aug 2026, 3:29 pm ISTvia CNBC Awaaz.

Entry₹2,903.2Inferred
Target₹3,000
Total upside +3.33% (call closed)
Stop loss₹2,850-1.83% risk
At expiry₹2,871.427 Aug 2026, 3:20 pm
Expired-1.10%
Follow Chandan Taparia for new calls(17% target hit, 48 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 3 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 27 Aug 2026
3 supporting0 opposing
Supports the BUY call (3)

Gland Pharma Signs CDMO Deal Targeting USD 90-100 Million Annual Revenue

NewsGoogle News·26 Aug · yesterday

(opens in new tab)

Gland Pharma FY26 Results: Net profit surges 47% to ₹10,273 mn

NewsGoogle News·25 Aug · yesterday

(opens in new tab)

The biggest upgrades and downgrades by Jefferies during the Q1 results season

NewsCnbc-Tv18·20 Aug · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.